Back to User profile » Prof. Dr. Jennifer Quint

Papers published by Prof. Dr. Jennifer Quint:


Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK

Rothnie KJ, Numbere B, Gelwicks S, Lu Y, Sharma R, Compton C, Ismaila AS, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2673-2685

Published Date: 21 November 2023

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions

Kallis C, Kaura A, Samuel NA, Mulla A, Glampson B, O'Gallagher K, Davies J, Papadimitriou D, Woods KJ, Shah AD, Williams B, Asselbergs FW, Mayer EK, Lee RW, Herbert C, Grant SW, Curzen N, Squire IB, Johnson T, Shah AM, Perera D, Kharbanda RK, Patel RS, Channon KM, Mayet J, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2405-2416

Published Date: 6 November 2023

Development of an Asthma Exacerbation Risk Prediction Model for Conversational Use by Adults in England

Kallis C, Calvo RA, Schuller B, Quint JK

Pragmatic and Observational Research 2023, 14:111-125

Published Date: 4 October 2023

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England

Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJ, Quint JK, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2039-2054

Published Date: 15 September 2023

Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019

Stone PW, Osen M, Ellis A, Coaker R, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1565-1574

Published Date: 21 July 2023

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England

Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1431-1444

Published Date: 13 July 2023

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England

Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:643-659

Published Date: 19 April 2023

“NEWS2” as an Objective Assessment of Hospitalised COPD Exacerbation Severity

Stone PW, Minelli C, Feary J, Roberts CM, Quint JK, Hurst JR

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:763-772

Published Date: 8 April 2022

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study

Whittaker H, Rubino A, Müllerová H, Morris T, Varghese P, Xu Y, De Nigris E, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:427-437

Published Date: 3 March 2022

Deriving a Standardised Recommended Respiratory Disease Codelist Repository for Future Research

MacRae C, Whittaker H, Mukherjee M, Daines L, Morgan A, Iwundu C, Alsallakh M, Vasileiou E, O’Rourke E, Williams AT, Stone PW, Sheikh A, Quint JK

Pragmatic and Observational Research 2022, 13:1-8

Published Date: 16 February 2022

Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D

Pragmatic and Observational Research 2021, 12:93-104

Published Date: 11 August 2021

Predicting Future Health Risk in COPD: Differential Impact of Disease-Specific and Multi-Morbidity-Based Risk Stratification

Groves D, Karsanji U, Evans RA, Greening N, Singh SJ, Quint JK, Whittaker H, Richardson M, Barrett J, Sutch SP, Steiner MC

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1741-1754

Published Date: 16 June 2021

Chronic Obstructive Pulmonary Disease (COPD) in Population Studies in Russia and Norway: Comparison of Prevalence, Awareness and Management

Cook S, Eggen AE, Hopstock LA, Malyutina S, Shapkina M, Kudryavtsev AV, Melbye H, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1353-1368

Published Date: 14 May 2021

Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial

Galani J, Mulder H, Rockhold FW, Weissler EH, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Hiatt WR, Katona BG, Norgren L, Mahaffey KW, Quint JK, Patel MR, Jones WS

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:841-851

Published Date: 29 March 2021

The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study

Requena G, Dedman D, Quint JK, Ghosh RE, Williams R, Pimenta JM

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:629-642

Published Date: 10 March 2021

Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus

Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:321-332

Published Date: 16 February 2021

Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK

Quint JK, Venerus A, O'Leary C, Myland M, Holmgren U, Varghese P, Cabrera C

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3261-3271

Published Date: 8 December 2020

Predictors of Referral to Pulmonary Rehabilitation from UK Primary Care

Stone PW, Hickman K, Steiner MC, Roberts CM, Quint JK, Singh SJ

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2941-2952

Published Date: 16 November 2020

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting

Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1063-1073

Published Date: 23 May 2019

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016

Bloom CI, Elkin SL, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:279-287

Published Date: 22 January 2019

Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)

Nissen F, Douglas IJ, Müllerová H, Pearce N, Bloom CI, Smeeth L, Quint JK

Journal of Asthma and Allergy 2019, 12:7-19

Published Date: 8 January 2019

Validation of asthma recording in electronic health records: a systematic review

Nissen F, Quint JK, Wilkinson S, Mullerova H, Smeeth L, Douglas IJ

Clinical Epidemiology 2017, 9:643-656

Published Date: 1 December 2017

Prognostic variables and scores identifying the end of life in COPD: a systematic review

Smith LE, Moore E, Ali I, Smeeth L, Stone P, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2239-2256

Published Date: 31 July 2017

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care

Rothnie KJ, Chandan JS, Goss HG, Müllerová H, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1663-1668

Published Date: 7 June 2017

Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records

Rothnie KJ, Müllerová H, Thomas SL, Chandan JS, Smeeth L, Hurst JR, Davis K, Quint JK

Clinical Epidemiology 2016, 8:771-782

Published Date: 21 November 2016

COPD disease severity and the risk of venous thromboembolic events: a matched case–control study

Morgan AD, Herrett E, De Stavola BL, Smeeth L, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:899-908

Published Date: 28 April 2016

No association between exacerbation frequency and stroke in patients with COPD

Windsor C, Herrett E, Smeeth L, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:217-225

Published Date: 2 February 2016